DCLK1 and colorectal cancer: DCLK1-IN-1 is a highly selective DCLK1 kinase inhibitor that has been shown in multiple experiments to inhibit the aggressiveness and stemness of colorectal cancer and reverse chemotherapy resistance [50, 51, 288].